These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2372911)

  • 21. Serum lipid profile in children of coronary heart disease patients.
    Ali W; Bandh A; Ul Hassan M
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):287-9. PubMed ID: 8550128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family study of serum lipids and lipoproteins in coronary heart-disease.
    Nikkilä EA; Aro A
    Lancet; 1973 May; 1(7810):954-9. PubMed ID: 4121585
    [No Abstract]   [Full Text] [Related]  

  • 23. [The risk and treatment of hyperlipoproteinemias].
    Alzamora P; Alegría E; Iglesias I
    Rev Med Univ Navarra; 1990; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum lipids and lipoproteins in children from families with early coronary heart disease.
    Ozme S; Ege M; Ozalp I; Ciliv G
    Turk J Pediatr; 1977; 19(1-2):67-72. PubMed ID: 618037
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.
    Breslow JL
    Annu Rev Genet; 2000; 34():233-254. PubMed ID: 11092828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic risk factors and coronary heart disease.
    Berg K; Pedersen JC
    Scand J Clin Lab Invest Suppl; 1990; 202():82-5. PubMed ID: 2150112
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
    Malamov E; Kiriakov A; Tsenov I; Kavrukova Iu; Kusitasev G
    Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
    Zhukova IM; Iurenev AP; Pomerantsev EV; Martynov AA; Shabalkin BV; Titov VN; Shimbaeva NA; Kotkina AA; Bochkova EI; Lediashova GA
    Ter Arkh; 1990; 62(8):130-3. PubMed ID: 2274859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein (a) as a risk factor for atherosclerotic diseases.
    Dahlén G
    Arctic Med Res; 1988; 47 Suppl 1():458-61. PubMed ID: 2978804
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease.
    Lipinska I; Gurewich V; Meriam CM; Kosowsky BD; Ramaswamy K; Philbin E; Losordo D
    Artery; 1987; 15(1):44-60. PubMed ID: 3435252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipoproteins, cholesterol and triglycerides in coronary heart disease.
    HAVEL RJ; CARLSON LA
    Metabolism; 1962 Feb; 11():195-7. PubMed ID: 13905467
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease.
    Bai H; Saku K; Liu R; Jimi S; Arakawa K
    J Cardiol; 1996 Oct; 28(4):207-12. PubMed ID: 8934336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoproteins and coronary heart disease].
    Windler E
    Verh Dtsch Ges Inn Med; 1989; 95():631-4. PubMed ID: 2690533
    [No Abstract]   [Full Text] [Related]  

  • 38. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
    Tatami R; Mabuchi H; Ueda K; Ueda R; Haba T; Kametani T; Ito S; Koizumi J; Ohta M; Miyamoto S; Nakayama A; Kanaya H; Oiwake H; Genda A; Takeda R
    Circulation; 1981 Dec; 64(6):1174-84. PubMed ID: 7296792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoproteins and apolipoproteins in the prediction of coronary artery disease.
    Assmann G
    Acta Med Scand Suppl; 1987; 715():67-77. PubMed ID: 3473917
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.